Kiniksa Pharmaceuticals International PLC (KNSA)
22.03
+0.55
(+2.56%)
USD |
NASDAQ |
Nov 05, 16:00
22.03
0.00 (0.00%)
After-Hours: 18:22
Kiniksa Pharmaceuticals International Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
--
Maximum
Jun 2021
--
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| OPKO Health Inc | 0.1447 |
| Ligand Pharmaceuticals Inc | 0.00 |
| Organon & Co | 17.75 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 555.30M |
| Total Liabilities (Quarterly) | 118.29M |
| Shareholders Equity (Quarterly) | 437.01M |
| Current Ratio | 3.244 |